Prescription drug · ANDA
VinCRIStine Sulfate NDC 61703-309
Vincristine sulfate 1 mg/mL · Injection, Solution · Intravenous · Hospira, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 61703-309-06 | 61703030906 | 1 VIAL, SINGLE-DOSE in 1 CARTON (61703-309-06) / 1 mL in 1 VIAL, SINGLE-DOSEMarketed from Jan 1, 1996 | |
| 61703-309-16 | 61703030916 | 1 VIAL, SINGLE-DOSE in 1 CARTON (61703-309-16) / 2 mL in 1 VIAL, SINGLE-DOSEMarketed from Jan 1, 1996 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- VinCRIStine Sulfate
- Generic name (nonproprietary)
- vincristine sulfate
- Active ingredients
- Vincristine sulfate — 1 mg/mL
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Labeler
- Hospira, Inc.NDC labeler code 61703
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 071484
- Marketing start
- Listing expires
- Other FDA classes
- Vinca Alkaloids (Chemical structure)
- Identifiers
- Product ID 61703-309_436f7772-e507-45ab-be60-4da4e0c889a8SPL ID 436f7772-e507-45ab-be60-4da4e0c889a8SPL set ID 49596de6-ab18-49d1-9e5b-30968fc21c36RxCUI 1863343, 1863354UNII T5IRO3534A
- Pharmacologic class
- Vinca Alkaloid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N461703030906followed by a unit qualifier and the quantityPackage 61703-0309-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE Vincristine Sulfate Injection is indicated in acute leukemia. Vincristine Sulfate Injection has also been shown to be useful in combination with other oncolytic agents in Hodgkin's disease, non–Hodgkin's malignant lymphomas, rhabdomyosarcoma, neuroblastoma, and Wilms' tumor.
Excerpt only. Read the full label for complete information.
About NDC 61703-309
- What is NDC 61703-309?
- 61703-309 is the product NDC for VinCRIStine Sulfate, Vincristine sulfate 1 mg/mL injection, solution, listed with the FDA by Hospira, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- VinCRIStine Sulfate.
- What is the active ingredient?
- Vincristine sulfate.
- Who is the labeler?
- Hospira, Inc., NDC labeler code 61703. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for VinCRIStine Sulfate?
- 1 other product NDC are listed under this name. See all VinCRIStine Sulfate NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.